颈动脉狭窄合并对侧颈动脉闭塞患者的颈动脉支架置入术:12年经验
该回顾性研究纳入2010至2021年接受颈动脉支架置入术的71例对侧颈动脉闭塞患者,围手术期卒中2例(2.8%)、死亡1例(1.4%);随访期间卒中2例(3.3%)、死亡6例(9.8%)。Kaplan-Meier分析显示侧支循环不足组卒中率高于对照组(P=0.009),症状性狭窄、年龄、支架类型及后扩张与长期卒中无关。
要点
- 对侧颈动脉闭塞患者行颈动脉支架置入术围手术期卒中率2.8%、死亡率1.4%。
- 随访期间卒中率3.3%、死亡率9.8%,平均随访63.3±30.4个月。
- 侧支循环不足组长期卒中率高于对照组(P=0.009)。
核心结论
- 颈动脉支架置入术是对侧颈动脉闭塞患者安全有效的治疗方法。
- 侧支循环不足与较高的长期卒中率相关。
- 症状性颈动脉狭窄、年龄、支架类型及后扩张对支架置入术后结局事件无显著影响。
研究设计与样本
- 回顾性收集2010年至2021年接受颈动脉支架置入术的对侧颈动脉闭塞患者数据。
- 共纳入71例连续患者,其中61例(86%)完成随访,随访时间9至134个月,平均63.3±30.4个月。
- 主要终点为非致死性主要卒中,次要终点包括脑出血、非致死性心肌梗死、再狭窄、急性肾功能不全、支架相关并发症及死亡。
- 采用Kaplan-Meier生存分析长期结局,变量包括症状性颈动脉狭窄、年龄、支架类型、侧支循环状态及后扩张。
主要发现
- 围手术期2例(2.8%)发生卒中,1例(1.4%)因脑出血合并脑疝死亡。
- 随访期间2例(3.3%)分别在支架置入术后4个月和6个月发生卒中,6例(9.8%)死亡(其中心肌梗死2例,严重肝衰竭、车祸、颈椎骨折或不明原因各1例)。
- Kaplan-Meier分析显示症状性颈动脉狭窄、年龄、支架类型及后扩张与长期卒中无关(P<0.05)。
- 侧支循环不足组卒中率高于对照组(P=0.009)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Carotid artery stenting (CAS) has emerged as a potential alternative for treating patients with extracranial cerebrovascular diseases. Contralateral carotid artery occlusion (CCO) occurs in approximately 2.3% to 25% of patients with carotid artery stenosis. However, the association of a CCO with long-term outcomes after CAS remains unclear. Here, we aimed to evaluate the perioperative and long-term recovery and safety of patients with CCO after receiving CAS. METHODS: We retrospectively collected the data of patients with CCO treated with CAS between 2010 and 2021. The primary end point was a nonfatal major stroke. The secondary end points included cerebral hemorrhage, nonfatal myocardial infarction, restenosis, acute renal insufficiency, stent-related complications, and death. Long-term outcomes were analyzed by Kaplan-Meier survival analysis using the following variables: symptomatic carotid stenosis, age, stent type, collateral flow status, and postdilation. RESULTS: Seventy one consecutive patients with CCO who underwent CAS were included in the study. Of these, 61 patients (86%) were followed up for 9-134 months, with an average of 63.3 ± 30.4 months. In the perioperative period, 2 patients (2.8%) experienced stroke and 1 patient (1.4%) died due to cerebral hemorrhage combined with cerebral hernia. During follow-up, 2 patients (3.3%) developed stroke at 4 and 6 months each after CAS and 6 patients (9.8%) died (2 patients died due to myocardial infarction and 4 patients died due to either severe liver failure, car accident, cervical fracture, or unknown cause). Kaplan-Meier survival analysis showed that symptomatic carotid stenosis, age, stent type, and postdilation were not associated with long-term stroke (P<0.05). The inadequate collateral flow group showed a higher stroke rate than the control group (P = 0.009). CONCLUSIONS: CAS is a safe and effective therapy for patients with CCO. Inadequate collateral flow is associated with a higher long-term rate of stroke. Our findings revealed that symptomatic carotid stenosis, age, stent type, and postdilation had no significant effect on outcome events after CAS.
引用
- Liang Z, Tang X, Chen Z, et al. Carotid Artery Stenting for Patients With Carotid Stenosis and Contralateral Carotid Artery Occlusion: A 12-Year Experience. Ann Vasc Surg. 2022. PMID: 36481673. doi:10.1016/j.avsg.2022.10.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。